MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference

Rhea-AI Summary

Mind Medicine (MindMed) announced its participation in the Cantor Fitzgerald Neurology & Psychiatry Conference from October 6-7, 2022, in San Francisco, CA. Members of the management team will be involved in panel presentations and one-on-one investor meetings. The panel titled 'Tripping our way to a new treatment paradigm for psychiatric disorders' is scheduled for October 6 at 12:10 p.m. PDT. MindMed aims to lead in developing innovative treatments for brain health disorders, focusing on drug candidates targeting serotonin, dopamine, and acetylcholine systems, trading under the symbol MNMD.

NEW YORK, Oct. 5, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that members of MindMed's management team will participate in the Cantor Fitzgerald Neurology & Psychiatry Conference, taking place at the Ritz Carlton, San Francisco, CA from October 6-7, 2022.

Cantor Fitzgerald Neurology & Psychiatry Conference
Format: Panel presentation and one-on-one investor meetings
Panel Title: "Tripping our way to a new treatment paradigm for psychiatric disorders: intermittent therapy vs chronic treatment"
Panel Date: Thursday, October 6, 2022
Panel Time: 12:10 p.m. PDT
Location: Ritz Carlton, San Francisco, CA

About MindMed

MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine, and acetylcholine systems.

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

For Media: media@mindmed.co

For Investors: ir@mindmed.co

View original content to download multimedia:https://www.prnewswire.com/news-releases/mindmed-to-participate-in-the-cantor-fitzgerald-neurology--psychiatry-conference-301641526.html

SOURCE Mind Medicine (MindMed) Inc.

FAQ

What conference is Mind Medicine participating in?

Mind Medicine is participating in the Cantor Fitzgerald Neurology & Psychiatry Conference.

When is the Cantor Fitzgerald Neurology & Psychiatry Conference?

The conference takes place on October 6-7, 2022.

What is the focus of MindMed's panel presentation?

MindMed's panel presentation focuses on 'Tripping our way to a new treatment paradigm for psychiatric disorders: intermittent therapy vs chronic treatment'.

When will MindMed's panel presentation occur?

The panel presentation is scheduled for October 6, 2022, at 12:10 p.m. PDT.

What is MindMed's mission?

MindMed's mission is to lead in developing and delivering treatments for brain health disorders.

What stock symbol does MindMed trade under?

MindMed trades under the stock symbol MNMD on NASDAQ.